T he generation ofblood leucocytes occurs from a population of multipotential stem cells, which undergo a series ofdifferentiation steps in which their multilineage potential is progressively restricted . This gives rise to populations of progenitor cells committed to the different leucocyte lineages. More is known about the later stages of these pathways since the discovery of the CSFs, but little is known about the mechanisms controlling the production of the progenitor cells .
Eosinophilia is characteristic of allergy and infection by helminths . One of the intriguing aspects of eosinophilia is its biological specificity, in which an increase in eosinophils can occur in the absence of increases in other leucocytes (1, 2). This suggests a lineage specific control mechanism . However, studies in vitro suggest that the sequential action of IL1 and IL3 or granulocyte colony-stimulating factor (G-CSF)t are necessary for progenitor cell production (3-5), and 1 Abbreviations used in this paper: DCR, dominant control region ; G-CSF, granulocyte colony-stimulating factor. 1425 that IL5 is responsible only for the differentiation of these progenitor cells into mature eosinophils (6) . As G-CSF stimulates the production of neutrophils and IL3 is active on many other lineages, a role for these factors in eosinophilia is paradoxical.
To define the activity of IL-5 in vivo, transgenic mice have been produced in which transcription of the IL5 gene is under the influence of the dominant control region (DCR) of the gene encoding human CD2 (8) (a T cell surface antigen). Detailed studies have shown that this region allows the expression of reporter genes in transgenic mice, which is constitutive, thymocyte and T cell specific, dependent on copy number, and independent of orientation or insertion site (8, 9) .
In this study we compare two transgenic lines of mice, each expressing different levels of 11,5, with mice infected with the cestode Mesocestoides corti. We show that constitutive expression ofthe IL5 gene is sufficient to induce lifelong high-level eosinophilia. The eosinophilia in both transgenic lines is at least as high as the peak eosinophilia observed in M. corti infection. Despite the wide tissue distribution of eosinophils, the transgenic animals remain physically normal .
Materials and Methods
Production and Analysis of Transgenic Mice. The human genomic CD2 DCR (8, 9) was obtained as a 5-kb BamHI-XbaI fragment in the vector polyIII-I. After excision of a 3-kb HindIII fragment, the 10-kb HindIII 11,5 genomic fragment (10) was ligated into the opened vector (Fig. 1) . The 12-kb hybrid gene was excised as a BamHI fragment and injected into CBA/Ca oocytes, which were then transferred to the oviducts of pseudopregnant (CBA/Ca x C57B6)F, mice using standard techniques (11) . Mice were maintained by the Institute animal facility. Southern blots were performed with DNA prepared from the tails of 9-30-d-old mice, and probed with a 650-bp fragment of 11, 5 cDNA (12) . Densitometnc analysis of Southern blots was performed using a Chromoscan 3 (Joyce Loebl, Deusseldorf, FRG) .
Total RNA was prepared by acid guanidinium thiocyanatephenol-chloroform extraction (13) , and 5-20 ugAample were electrophoresed through formaldehyde/agarose gels . Northern blot analysis was performed as described (14) using the IL5 cDNA probe described above and a riboprobe prepared from actin cDNA (15) . Restriction endonucleases and other enzymes were obtained from Boehringer Mannheim (Lewes, UK) or Northumbria Biologicals Ltd. (Cramlington, UK). All other reagents were from standard commercial sources. All techniques not specifically referenced were performed using standard methods (16) .
Cytokine andEosinophil Progenitor Assays. 11,5 was obtained from COS cells transfected with recombinant mouse (rm) IL5 cDNA (10) . 11,5 was assayedby the eosinophil differentiation assay (EDA) (17) . Briefly, sample dilutions were incubated in microplates with bone marrow from M. cortiinfected mice for 5 d. Eosinophil numbers were determined indirectly by assaying for eosinophil peroxidase . Absorbance (A492) was read in a plate reader, using cultures incubated in the absence of exogenous 11,5 as blanks .
Eosinophil progenitors were determined indirectly by titrating bone marrow cells in the presence of a predetermined optimum concentration of rmIIr5 and by bone marrow responsiveness to IL5.
IIr3/GM-CSF levels were determined by using the factordependent cell line FDCP-2, which detects both of these cytokines (18) .
Cytology and Histology. Slides for differential cell counts were prepared from single cell suspensions using a cytocentrifuge, or as standard blood films, fixed with methanol and stained with Giemsa . 2-5 x 102 cells were counted per slide. Tissues were fixed 
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Eosinophilia in Interleukin 5 Transgenic Mice in neutral buffered formalin, embedded in paraffin and 4-6-Am sections were stained with Congo Red (19) and counterstained with haematoxylin .
Results
Transgenic Mouse Lines. Four transgenic offspring were detected, initially by high eosinophil counts in a smear of tail blood (counts in excess of 45% at 9 d of age, compared with a mean of 3% in normal littermates), and later by Southern analysis of tail DNA. Of 341ivebirths only these 4 animals had increased blood eosinophil counts, and only these 4 were transgenic by Southern analysis . Independent transgenic lines have been established from all four of these founder animals and are designated Tg(0IL5)Cl, 7g(01L5)C2, Tg(0IL5)C3, and Tg(OIL5)C4, abbreviated Tg5C1, Tg5C2, Tg5C3, and Tg5C4, respectively. Blood eosinophilia in transgenic offspring of each line was comparable to that seen in founders . Data for Tg5C1 and Tg5C2 are presented here . Southern analysis of Sacl digests indicated they carry ti8 and 49 copies of the transgene, respectively (mean densitometry curve integrals of 4,626 and 28,272 U for Tg5C1 and Tg5C2, respectively, relative to a mean of 591 U for nontransgenic littermate DNA) .
IL5 Transgene Expression Is Tissue Restricted. Northern blot analysis identified 11,5 mRNA in the thymus, Peyer's patches, and subcutaneous (pooled inguinal and axillary) lymph nodes (Fig. 2 a) . No IL5 mRNA was detected in liver, heart, brain, or skeletal muscle tissues from transgenics (not shown), nor in any tissues from normal littermates . The presence of in- Values are means ± 1 SD, excepting differential counts (mean cells/ml and percent ± SD were also calculated, but added little to the analysis and so have been omitted) . Spleen weight and serum IL-5 levels (n -3). Blood cell counts for 9-12-wk-old transgenic mice (n -5), M. corti-infected mice (n = 2), normal littermates (n = 5) . Normal mice were counted for each category, but were not significantly different from the normal group presented . tact mRNA was confirmed using an actin RNA probe (Fig.  2 b) . Using three different preparative procedures intact mRNA was not obtained from transgenic spleen. This is thought to be due to RNase activity associated with the high levels of eosinophils in this tissue.
11,5 Levels and Eosinophil Counts in the Blood. 11,5 levels in sera from transgenic mice were comparable to peak levels in sera from mice infected with M. corti (Table 1) . No IL3 or GM-CSF activity was detected in the same sera.
Tg5C1 and Tg5C2 lines had 65-fold and 265-fold, respectively, the blood eosinophils seen in normal littermates, while M. corti-infected mice were 35-fold over normal controls (Table  1) . Transgenic mice also showed small but significant increases (up to threefold) in neutrophil, lymphocyte, and monocyte numbers relative to normal littermates .
Thus, comparing the two transgenic lines, eosinophilia and IL-5 levels were significantly higher in the line with the highest transgene copy number. Transgenic mice have been observed for up to 6 mo and eosinophilia was maintained at relatively stable levels during this period.
11,5 Production in Transgenic Cell Cultures. Supernatants from unstimulated transgenic spleen cell cultures contained 1175, indicating constitutive production, and this was increased markedly in the presence of ConA. None was detectable in supernatants from unstimulated normal spleen cells or spleen cells from mice infected with M. corti (Table 2) . Surprisingly, although high levels of mRNA were detected in transgenic thymus, no 1175 was constitutively produced in culture. However, when cultured with Con A, very high levels of 11,5 were detected (Table 2) .
In contrast, the levels of IL3/GM-CSF detected in transgenic spleen and thymus cell cultures were similar to normal spleen cultures, and negligible relative to supernatants from the IL3-producing cell line WEHI-3D.
Tissue Distribution of Eosinophils. Total and differential counts on single cell suspensions prepared from various tissues revealed major eosinophil localisation in the spleen, bone 142 7
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Blood cells/ml (x 10-s) marrow, and peritoneal exudate (Fig. 3) . Both the bone marrow and the spleen contained many morphologically immature forms, indicating active eosinophil haemopoiesis in both organs . Transgenics had enlarged spleens (Table 1) , with a high proportion of eosinophils relative to nontransgenic littermates. Both transgenic lines had a high percentage of eosinophils in the peritoneal exudate, although the total number was lower than from mice infected with M. corti . For example, the approximate total numbers of peritoneal eosinophils for Tg5C1, Tg5C2, and parasitized mice were 2 x 106, 5 x 106, and 20 x 106, respectively. Eosinophils represented 1% of thymocytes and 3% ofmesenteric lymph node cells recovered from transgenics. Although relatively low compared with the spleen these are significantly higher than normal littermates, where eosinophils were virtually undetectable.
Values are means ± 1 SD of 50% endpoints of replicate culture supernatants in each assay . WEHI-3D-conditioned medium gave 5,744 U in the IL-3/GM-CSF assay . Histological sections showed that most of the eosinophils in the spleen were located in the red pulp with very few in the white pulp area (Fig. 4 , a and b; transgenic and normal, respectively). It was also noted that the lungs of transgenic but not of normal animals were heavily infiltrated with eosinophils (Fig. 4, c and d, respectively) . Small but significant numbers of eosinophils were also observed in sections ofmesenteric lymph nodes, peyer's patches, and lamina propria of the small intestine from transgenics. None of the other tissue sections examined (heart, liver, skeletal muscle, or brain) showed increased numbers of eosinophils.
IL5-responsive Eosinophil Precursors in Bone Marrow. Limiting dilution culture ofbone marrow in the presence ofIL5 indicated that cells from transgenics had >10-fold higher capacity to produce eosinophils than normal littermates (Fig.  5) . The capacity of transgenic marrow was also higher than that of bone marrow from mice infected with M. corti.
Another indirect measure of eosinophil progenitors is the sensitivity of the bone marrow to detect IL5 . This is illustrated in Fig . 6 where the bone marrow can be ranked in order of increasing sensitivity : normal, M. corti, Tg5C1 and Tg5C2. Although not obvious in these data the bone marrow from M. corti-infected mice is several orders of magnitude more sensitive than normal bone marrow (1) .
Discussion
We report here the generation of four founder mice carrying transgenes for the cytokine IL5. All four mice were eosinophilic, and independent lines have been established from each. Two of these lines carrying 8 or 49 copies of the transgene are reported here. The transgene was constructed by ligating a 2-kb fragment of human genomic DNA containing the DCR of the human CD2 gene (8) to a 10-kb DNA fragment containing the mouse IL5 gene (10) . The DCR was placed 5' of the IL-5 gene. The murine fragment included 1428 Eosinophilia in Interleukin 5 Transgenic Mice flanking sequences of -4 kb upstream from the 11,5 cap site, and 1.3 kb downstream from the polyadenylation attachment site of the 11,5 gene. These flanking regions are likely to contain many of the elements controlling the expression of the IL-5 gene, including the IL5 promoter. Thus, while transcription is occurring from the IL5 promoter, the CD2 DCR is acting to override other normal transcriptional controls on the IL5 gene, allowing constitutive secretion of 11,5. The level ofconstitutive transgene expression has not been established, but may be lower than the induced expression of the endogenous gene. For example, the levels of IL5 detected in transgenic sera are not as high as might be anticipated from the number of transgenes, when compared with the levels produced following expression by the single gene in normal mice infected with M. corti. It is possible that the transgenes retain the capacity to show normal inducible expression in response to activation. Some evidence for this is seen in the high levels of 11,5 produced by transgenic lymphoid organs after the addition of Con A. Although the thymus of Tg5C1 contained high levels of IL5 mRNA no 11,5 was secreted except after addition ofCon A. This failure to secrete IL5 constitutively in culture is puzzling, and it is not clear whether it represents a real inability to secrete, or simply a failure to secrete in vitro. Spleen cells secreted IL5 constitutively in vitro and this was further increased after addition of ConA. In contrast little or no IL-3 or GMCSF was detected from either cell type.
The level of expression of other CD2 DCR transgene constructs is dependent upon transgene copy number and is T cell-specific (8, 9) . Similarly, serum IL5 levels and tissue eosinophilia were higher in the IL5 transgenic line with the greatest copy number (Tg5C2) . Further, IL5 mRNA transcription patterns are consistent with transgene expression restricted to lymphoid tissues .
Both transgenic lines had profound, continuous eosinophilia in the blood, lymphoid, and hematopoietic tissues. Extensive eosinophilic infiltration of the lungs and intestinal lamina propria was also noted . Bone marrow from transgenics was rich in eosinophil progenitors as indicated by the number of immature cells observed, and by increased responsiveness to 116 . Transgenics were compared with mice infected with the helminth M. corti, a pathogen known to induce high levels of eosinophilia and elevated serum IL5 (1). In most tissues the numbers ofeosinophils were higher in the transgenic lines compared with parasite-infected animals, although it must be remembered that eosinophilia in the parasitized mice is only transient and the animals included in this study may not have been at peak eosinophilia (1) .
These transgenic mice raise some interesting points about the control of eosinophilia. Since its first characterization, studies in vitro have suggested that 11,5 is a late-acting factor in eosinophil differentiation (3-7) . Eosinophils were produced only transiently in long-term bone marrow cultures stimulated with exogenous IL5, suggesting that at least in these systems the progenitor cells were not being produced from stem cells . In addition, bone marrow from eosinophilic parasite-infected mice gives rise to many more eosinophils than bone marrow from normal mice, indicating that the parasitic infection stimulates the production ofprogenitors . This suggests that other cytokines may be inducing the progenitors, and indeed it has been shown that ILl, IL3, and possibly G-CSF and GM-CSF are involved in this process (4, 6) . Similarly, in studies with human bone marrow, both IL3 and GM-CSF but not IL5 induced eosinophil precursors, assayed as IL5-responsive colony-forming cells (5, 7) . However, the transgenics show that IL5 expression is sufficient to induce eosinophilia, which suggests that IL5 in vivo is able to control the production of eosinophil progenitors. Although a role for other cytokines in this process cannot be ruled out, they must be either constitutively expressed or their expression is induced by 11,5. It should be noted that no significant production of IL3 or GM-CSF was detected, and so there is no apparent induction of these cytokines in the transgenic mice.
It has recently been shown that parasite-induced eosinophilia can be blocked by the in vivo administration ofanti-M5 mAbs 142 9 Dent et al. (20, 21) . Thus, while both IL3 and GM-CSF induce eosinophil production in vitro, these experiments in vivo suggest that IIr3 and GM-CSF do not operate in the development of eosinophilia in parasitic infections. Together with these results, the present study of IIr5 transgenic mice points to a major role for IL5 in the control ofeosinophilia. This provides an explanation for the biological specificity of eosinophilia (1, 2), as it appears that cytokines such as 11,3 and GM-CSF are not primarily involved in its induction . In both transgenic lines there was a small but significant increase in blood neutrophils and monocytes . It is not clear whether this represents a direct effect ofIL5 on these lineages, or whether it is secondary to the large turnover ofeosinophils. It should be noted that studies in vitro showed a decrease in neutrophil numbers in bone marrow cultures containing IIr5 (3) . 11,5 also has a well-characterized activity on B cells, with more recent reports of activities on T cells (reviewed in reference 22). Although there were also increases in lymphocyte numbers in transgenics relative to nontransgenic controls, the changes were marginal compared with the magnitude of the eosinophil response. Preliminary flow cytometric analysis has not revealed any major selective increases in T or B cell subsets. Further experiments are being carried out to clarify these issues . In the design of these transgenic animals we have been aware of the T cell dependence of eosinophilia, and the fact that IM is normally a T cell product (23) . The use of the CD2 DCR should ensure constitutive expression by T cells, and 1. Strath, M., and C.J . Sanderson. 1986 . Detection of eosinophil differentiation factor and its relationship to eosinophilia in Mesocestoides cord infected mice . Expt Haematol. 14 :16. the data are consistent with this tissue-restricted expression . It seems remarkable that animals with such high levels of a potentially damaging leukocyte remain normal . This suggests that eosinophils require other factors, for example antigen-antibody complexes, for degranulation and subsequent tissue damage. As eosinophils play a role in allergic diseases in man (24) , these animals will provide a model for testing modifiers of eosinophil production.
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